Sanofi (SNY)
(Delayed Data from NSDQ)
$49.36 USD
+2.75 (5.90%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $49.31 -0.05 (-0.10%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth F Momentum B VGM
Price, Consensus and EPS Surprise
SNY 49.36 +2.75(5.90%)
Will SNY be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for SNY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SNY
AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up
Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up
SNY: What are Zacks experts saying now?
Zacks Private Portfolio Services
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Sanofi (SNY) Rilzabrutinib Shows Benefit in Blood Disorder Study
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Other News for SNY
Sanofi Non-GAAP EPS of €1.78, revenue of €10.46B; reaffirms FY24 business EPS guidance
Sanofi 2024 Q1 - Results - Earnings Call Presentation
TOP NEWS: Sanofi in "excellent" start to 2024 as Dupixent sales jump
Sanofi SA Starts 2024 with Strong Sales Growth
Sanofi (SNY) Q1 2024 Earnings Call Transcript